Sleep, Mood & Brain Fog in Perimenopause and Menopause: Understanding Evidence-Based Management Pathways [Menopause Symptoms & Systems Series (Part 3 of 3)]
- hello1993677
- Apr 1
- 3 min read
In Part 1, we explored why sleep and fatigue commonly change during perimenopause and menopause, and why these symptoms are often multifactorial.
In Part 2, we looked at why sleep disturbance, anxiety, low mood, and cognitive symptoms such as “brain fog” so often occur together — and why they are best understood as interconnected systems.

In Part 3, we bring this together by outlining how clinicians think about evidence-based management pathways for these symptoms, and why an individualised, stepwise approach is supported by current clinical guidance.
Why there is no single “right” treatment
Because sleep disturbance, mood changes, anxiety, and cognitive symptoms are influenced by multiple overlapping factors, there is no one-size-fits-all solution.
Management is most effective when it:
Identifies the dominant contributors for that individual
Prioritises symptoms that are most disruptive to quality of life
Considers preferences, health history, and contraindications
Uses evidence-based options in a thoughtful, staged way
This is why menopause care often looks different from person to person.
A sleep-first lens
Sleep is often a key driver of other symptoms.
Fragmented or insufficient sleep can worsen:
Anxiety and emotional reactivity
Low mood
Concentration and memory efficiency
Stress tolerance
For this reason, clinical assessment frequently starts with understanding sleep patterns and contributors, even when mood or cognitive symptoms are the primary concern.
Non-pharmacological approaches
Insomnia-focused therapies
For women experiencing persistent insomnia, cognitive behavioural therapy for insomnia (CBT-I) is recognised as a first-line, evidence-based approach.
CBT-I focuses on:
Sleep behaviours and routines
Sleep drive and circadian timing
Thought patterns that perpetuate insomnia
International guidance recognises CBT-I — including menopause-specific CBT approaches — as appropriate for menopause-related sleep disturbance.
Lifestyle and behavioural strategies
Supportive strategies may include:
Establishing consistent sleep–wake times
Reducing factors that fragment sleep (such as alcohol sensitivity)
Managing cognitive and emotional load
Supporting stress regulation
These approaches are often used alongside other management options.
Hormonal therapy considerations
Hormonal changes during the menopause transition can increase sensitivity within sleep, mood, and cognitive systems.
For some women, menopausal hormone therapy (MHT) may be considered as part of management following careful individual assessment. International guidance recognises that addressing vasomotor symptoms may improve sleep and quality of life for some women.
However:
Hormones are rarely the only factor
Hormonal therapy is not appropriate for everyone
Benefits and risks must be considered individually
Hormonal therapy, where appropriate, is typically part of a broader management plan rather than a standalone solution.
Non-hormonal medical options
For women who are unable or prefer not to use hormone-based therapies, evidence-based non-hormonal options may be considered.
These may be used to support:
Vasomotor symptoms
Sleep disruption
Mood or anxiety symptoms
International menopause guidance recognises non-hormonal therapies as valid options when clinically appropriate.
Supporting mood, anxiety, and cognitive symptoms
Where anxiety, low mood, or cognitive symptoms are prominent, management may involve:
Addressing sleep disruption
Psychological or behavioural therapies
Reviewing contributing medical factors
Considering broader mental health supports where indicated
Distinguishing menopausal vulnerability from primary mental health conditions is an important part of assessment.
The importance of individualised care
Effective menopause care does not focus on a single symptom or system in isolation.
A structured approach considers:
Symptom patterns and severity
Sleep quality
Hormonal stage and symptoms
Physical and mental health history
Lifestyle context and stressors
Individual preferences and goals
This whole-picture approach is supported by current clinical guidance and reflects how menopause care is delivered in practice.
Key takeaway
Sleep disturbance, mood changes, anxiety, and cognitive symptoms during perimenopause and menopause are common, interconnected, and highly individual.
Evidence supports a stepwise, personalised approach that may include behavioural strategies, psychological therapies, hormonal and non-hormonal options, and lifestyle support — selected according to individual needs and circumstances.
If you would like to seek further information about these symptoms or learn more about assessment options, you can contact Menopause & Me:
You’re not alone on this journey: knowledge is power!
Warm Regards,
Jenna Bell
Nurse Practitioner & Menopause Educator
Sources
Australasian Menopause Society | International Menopause Society | North American Menopause Society | NICE Guidelines NG23
Important Disclaimer: The information in this blog/newsletter is general in nature and intended for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your Nurse Practitioner, doctor, or another qualified health practitioner with any questions you may have regarding a medical condition or before commencing any new treatment, exercise program, changing your diet, or taking supplements – particularly if you have existing health conditions, are on medication, or have had fractures or falls in the past. Individual needs and responses vary.





Comments